The federal government’s cost recovery policy for regulatory programs stifles science-based innovation and a Treasury Board (TB) draft paper outlining a new policy is only compounding the problem. The result is reduced R&D investment, fewer science-based jobs and lost sales of nearly half a billion dollars.